372 related articles for article (PubMed ID: 27050696)
1. Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: A Review.
Seale LR; Eglini AN; McMichael AJ
J Drugs Dermatol; 2016 Apr; 15(4):414-9. PubMed ID: 27050696
[TBL] [Abstract][Full Text] [Related]
2. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
Said MA; Mehta A
Curr Urol Rep; 2018 Jun; 19(8):65. PubMed ID: 29909472
[TBL] [Abstract][Full Text] [Related]
3. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
Shanshanwal SJ; Dhurat RS
Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
[TBL] [Abstract][Full Text] [Related]
4. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.
Iamsumang W; Leerunyakul K; Suchonwanit P
Drug Des Devel Ther; 2020; 14():951-959. PubMed ID: 32184564
[TBL] [Abstract][Full Text] [Related]
5. Dutasteride in Androgenetic Alopecia: An Update.
Arif T; Dorjay K; Adil M; Sami M
Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
[TBL] [Abstract][Full Text] [Related]
6. Guidelines on the use of finasteride in androgenetic alopecia.
Mysore V; Shashikumar BM
Indian J Dermatol Venereol Leprol; 2016; 82(2):128-34. PubMed ID: 26924401
[TBL] [Abstract][Full Text] [Related]
7. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss.
Won YY; Lew BL; Sim WY
Dermatol Ther; 2018 Mar; 31(2):e12588. PubMed ID: 29464847
[TBL] [Abstract][Full Text] [Related]
9. Persistent sexual side effects of finasteride for male pattern hair loss.
Irwig MS; Kolukula S
J Sex Med; 2011 Jun; 8(6):1747-53. PubMed ID: 21418145
[TBL] [Abstract][Full Text] [Related]
10. 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss.
Yeon JH; Jung JY; Choi JW; Kim BJ; Youn SW; Park KC; Huh CH
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):211-4. PubMed ID: 20569283
[TBL] [Abstract][Full Text] [Related]
11. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Gupta AK; Talukder M; Williams G
J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
[TBL] [Abstract][Full Text] [Related]
12. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
Arias-Santiago S; Camacho-Martínez FM
Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801
[No Abstract] [Full Text] [Related]
13. Persistent sexual side effects of finasteride: could they be permanent?
Irwig MS
J Sex Med; 2012 Nov; 9(11):2927-32. PubMed ID: 22789024
[TBL] [Abstract][Full Text] [Related]
14. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
Traish AM; Hassani J; Guay AT; Zitzmann M; Hansen ML
J Sex Med; 2011 Mar; 8(3):872-84. PubMed ID: 21176115
[TBL] [Abstract][Full Text] [Related]
15. 5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based treatment update.
Murad A; Bergfeld W
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1385-1390. PubMed ID: 29524253
[TBL] [Abstract][Full Text] [Related]
16. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
Coskuner ER; Ozkan B; Culha MG
Sex Med Rev; 2019 Apr; 7(2):277-282. PubMed ID: 30301703
[TBL] [Abstract][Full Text] [Related]
17. Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature.
Suchonwanit P; Iamsumang W; Leerunyakul K
J Dermatolog Treat; 2022 Mar; 33(2):643-648. PubMed ID: 32538225
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and use of finasteride in women: a systematic review.
Hu AC; Chapman LW; Mesinkovska NA
Int J Dermatol; 2019 Jul; 58(7):759-776. PubMed ID: 30604525
[TBL] [Abstract][Full Text] [Related]
19. 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study.
Kang MJ; Choi JY; Sim WY; Lew BL
J Am Acad Dermatol; 2021 Jan; 84(1):172-173. PubMed ID: 32320771
[No Abstract] [Full Text] [Related]
20. Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
Belknap SM; Aslam I; Kiguradze T; Temps WH; Yarnold PR; Cashy J; Brannigan RE; Micali G; Nardone B; West DP
JAMA Dermatol; 2015 Jun; 151(6):600-6. PubMed ID: 25830296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
